Genetic risk factor and viral infection jointly contribute to multiple sclerosis, study suggests

Recent findings suggest that the Epstein-Barr virus (EBV) is involved in both causing multiple sclerosis (MS) and shaping its ...

Essential Tremor Management: From Pharmacotherapy to Surgery and More

Management of Essential Tremor prioritizes functional improvement over symptom elimination, and protocols begin with ...
guardonline.com

GridAI's Role at the Center of Grid Intelligence Economics

BOCA RATON, FL / / January 13, 2026 / Infrastructure narratives are easy to tell. Execution narratives are harder, and far ...

10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Brigham & Women's Hospital, a world-class academic medical center, to analyze peripheral ...
RMD Open

Spotlight on Sjögren’s: a patient perspective on burden of illness and unmet needs – results from a real-world survey

Objective Sjögren’s is a chronic systemic autoimmune disease characterised by dryness symptoms (eyes, mouth, skin), alongside ...

CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...

Solid Biosciences Doses First Participant in First-in-Class Phase 1b FALCON Trial Evaluating SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia

About the FALCON Trial FALCON is a first-in-human, open-label, multi-center Phase 1b clinical trial designed to evaluate the safety and tolerability of SGT-212 in participants aged 18-40 who have been ...